Final answer:
Correct actions must be taken if a prescription is administered before pharmacist review, including a risk assessment and patient monitoring, to ensure patient safety and adherence to FDA regulations. The pharmacist's review is important to verify the accuracy and safety of a medication order, and regulations by the FDA protect patients, though sometimes at the cost of delayed medication access.
Step-by-step explanation:
If a prescription order is administered before the pharmacist reviews it, corrective actions need to be taken immediately. This includes conducting a thorough risk assessment, reporting the incident as per the institutional protocols, monitoring the patient closely for any adverse effects, and providing appropriate care if needed. This is essential to maintain patient safety, uphold the integrity of the healthcare system, and comply with regulatory standards, including those set by the Food and Drug Administration (FDA).
Prescriptions are a critical component of patient care and the role of the pharmacist in reviewing medication orders before they are administered is paramount. The oversight by a pharmacist ensures the correct medication, dosage, and administration method, along with checks for potential drug interactions or contraindications. Failure to have a prescription reviewed may bypass these safeguards and possibly lead to medication errors.
Regularly, the FDA mandates that drugs are tested for safety and efficacy, often requiring extensive time periods before a medication can enter the market. This regulation serves as a protective measure for the public, but can also result in delayed access to medications, which presents a disadvantage to patients who might benefit from earlier access to new therapies.